2m 2m 2m 2m 2m 2m 2m
Evolent Health-A (EVH)
NYSE
$4.82+$0.02 (+0.31%)
Price as of Jun 23, 2026 7:17 PM EDT- $503.9MMarket Cap
- -54.80%1-Year Change
- Health Information ServicesIndustry
Evolent Health-A (EVH)
$4.82+$0.02 (+0.31%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.9B -26.56% | 2.6B +30.09% | 2.0B +45.26% | 1.4B +48.91% | |
Cost of Revenue | 1.5B -32.51% | 2.2B +45.49% | 1.5B +45.20% | 1.0B N/A | |
Gross Profit | 399.9M +8.86% | 367.4M -20.22% | 460.5M +45.45% | 316.6M -65.13% | |
Sales and Marketing Expense | 303.9M +15.52% | 263.1M -26.54% | 358.1M +32.99% | 269.3M +22.67% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 115.9M -2.13% | 118.4M -4.09% | 123.4M +83.67% | 67.2M +11.92% | |
Total Operating Expenses | 2.3B -11.90% | 2.6B +27.52% | 2.0B +50.93% | 1.3B +41.88% | |
Operating Profit | -410.1M +913.06% | -40.5M -43.15% | -71.2M -2,055.27% | 3.6M +108.59% | |
Interest Income | 4.2M -24.42% | 5.5M +5.48% | 5.3M +283.93% | 1.4M +236.36% | |
Interest Expense | 0 +100.00% | -14.1M -74.01% | -54.2M +248.09% | -15.6M -38.75% | |
Interest Income and Expense and Net | 4.2M +149.05% | -8.5M -82.55% | -48.9M -3,675.53% | 1.4M +236.36% | |
Total Nonoperating Income and Expense | 249,000 +3.32% | 241,000 +144.38% | -543,000 -1,052.63% | 57,000 -99.78% | |
Income before Taxes | -534.6M +748.14% | -63.0M -68.86% | -202.4M +226.05% | -62.1M +108.31% | |
Income Taxes | -126,000 -91.08% | -1.4M -98.42% | -89.4M +106.02% | -43.4M -9,080.54% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -534.5M +767.39% | -61.6M -45.49% | -113.0M +489.86% | -19.2M -49.03% | |
Net Income from Continuing Operations Applicable to Common | -579.4M +840.23% | -61.6M -45.49% | -113.0M +504.46% | -18.7M -50.26% | |
Basic EPS and Net Income | -5.07 +525.93% | -0.81 -36.72% | -1.28 +540.00% | -0.20 -54.55% | |
Diluted EPS and Net Income | -5.07 +525.93% | -0.81 -36.72% | -1.28 +540.00% | -0.20 -54.55% | |
Basic Weighted Average Shares | 114.2M -0.41% | 114.7M +3.08% | 111.3M +18.73% | 93.7M +8.87% | |
Diluted Weighted Average Shares | 114.2M -0.41% | 114.7M +3.08% | 111.3M +18.73% | 93.7M +8.87% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 151.9M +45.73% | 104.2M -45.96% | 192.8M +2.46% | 188.2M -29.32% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 151.9M +45.73% | 104.2M -45.96% | 192.8M +2.46% | 188.2M -29.32% | |
Total Current Assets | 506.4M -16.59% | 607.1M -11.20% | 683.7M +43.01% | 478.1M -8.76% | |
Accumulated Depreciation | 205.8M +14.40% | 179.9M +13.44% | 158.6M +5.38% | 150.5M +26.35% | |
Property and Plant and Equipment and Net | 80.8M +10.44% | 73.2M -6.45% | 78.2M -11.02% | 87.9M +8.00% | |
Total Long-Term Assets | 80.8M +10.44% | 73.2M -6.45% | 78.2M -11.02% | 87.9M +8.00% | |
Total Assets | 1.9B -25.36% | 2.5B -5.07% | 2.7B +47.49% | 1.8B +28.03% | |
Income Taxes Payable | 7.5M -31.14% | 10.9M -18.11% | 13.3M +180.59% | 4.7M +238.13% | |
Total Short-Term Debt | 0 -100.00% | 171.5M +357.25% | 37.5M N/A | N/A N/A | |
Total Current Liabilities | 385.3M -46.16% | 715.5M +6.12% | 674.2M +55.56% | 433.4M -2.71% | |
Total Long-Term Debt | 970.5M +97.86% | 490.5M -17.84% | 597.0M +44.57% | 413.0M +91.48% | |
Total Long-Term Liabilities | 8.0M +168.50% | 3.0M -17.95% | 3.6M -23.33% | 4.7M -14.23% | |
Total Liabilities | 1.5B +9.69% | 1.4B -5.66% | 1.4B +49.73% | 957.9M +31.97% | |
Retained Earnings | -1.3B +68.46% | -780.8M +8.57% | -719.2M +18.65% | -606.2M -3.29% | |
Total Stockholders Equity | 415.2M -58.53% | 1.0B -6.22% | 1.1B +24.24% | 859.4M +23.90% | |
Total Shares Outstanding | 117.6M +0.88% | 116.6M +1.00% | 115.4M +13.72% | 101.5M +11.84% | |
Cash Flow | |||||
Cash from Operating Activities | 38.8M +107.00% | 18.8M -86.84% | 142.6M +1,334.16% | -11.6M -129.82% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -233,000 -99.63% | -62.9M -84.86% | -415.5M +60.37% | -259.1M +1,541.42% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -35.9M +6,258.23% | -565,000 -100.20% | 281.3M +113.88% | 131.5M +545.18% | |
Financials Ratio | |||||
Gross Margin | 21.31% +48.22% | 14.38% -38.67% | 23.45% +0.13% | 23.42% N/A | |
Operating Margin | -21.86% +1,279.42% | -1.58% -56.30% | -3.63% -1,445.95% | 0.27% +105.77% | |
Return on Assets | -24.06% +919.85% | -2.36% -53.07% | -5.03% +324.48% | -1.18% -56.07% | |
Return on Equity | -75.47% +1,166.96% | -5.96% -49.22% | -11.73% +375.36% | -2.47% -56.90% | |
Revenue Growth | -26.56% -188.28% | 30.09% -33.52% | 45.26% -7.46% | 48.91% +536.81% | |
Current Ratio | 1.31 +54.91% | 0.85 -16.32% | 1.01 -8.06% | 1.10 -6.22% | |
Cash Ratio | 0.39 +170.74% | 0.15 -49.09% | 0.29 -34.13% | 0.43 -27.35% | |
Debt-to-Equity Ratio | 2.34 +253.54% | 0.66 +11.26% | 0.59 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.51 +96.39% | 0.26 +9.93% | 0.24 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow